PE20030358A1 - Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas - Google Patents

Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas

Info

Publication number
PE20030358A1
PE20030358A1 PE2002000744A PE2002000744A PE20030358A1 PE 20030358 A1 PE20030358 A1 PE 20030358A1 PE 2002000744 A PE2002000744 A PE 2002000744A PE 2002000744 A PE2002000744 A PE 2002000744A PE 20030358 A1 PE20030358 A1 PE 20030358A1
Authority
PE
Peru
Prior art keywords
aryl
active substances
amine derivatives
alkyl
formulation
Prior art date
Application number
PE2002000744A
Other languages
English (en)
Inventor
Heiner Glombik
Wendelin Frick
Hans-Ludwig Schafer
Werner Kramer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10140170A external-priority patent/DE10140170A1/de
Priority claimed from DE2001142455 external-priority patent/DE10142455A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PE20030358A1 publication Critical patent/PE20030358A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE PROPANOL AMINA SUSTITUIDOS CON ARILO DONDE R1 ES FENILO, HETEROARILO CON 1-3 RADICALES PUDIENDO EL RESTO AROMATICO ESTAR SUSTITUIDO DE 1 A 3 VECES CON F, Cl, Br, I, OH, CF3, -NO2, CN, ALCOXI C1-C8, ALQUILO C1-C8, ENTRE OTROS; R2 ES H, OH, CH2OH, OMe, CHO, NH2; R3 ES UN RADICAL AZUCAR CON GRUPOS PROTECTORES COMO HO-SO2, (HO)2-PO-; R4 ES H, METILO, F, OMe; R9 - R12 SON H, ALQUILO C1-C8; Z ES -NH-ALQUIL C0-C16-C=O, -O-ALQUIL C0-C16=O-, ENTRE OTROS; n Y m SON 0-1; SE REFIERE TAMBIEN A UNA COMBINACION FARMACEUTICA QUE CONTIENE UNO O VARIOS AGENTES ANTIDIABETICOS, SUSTANCIAS ACTIVAS HIPOGLUCEMICAS
PE2002000744A 2001-08-22 2002-08-16 Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas PE20030358A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10140170A DE10140170A1 (de) 2001-08-22 2001-08-22 Kombinationspräparate von arylsubstituierten Propanolaminderivaten mit weiteren Wirkstoffen und deren Verwendung
DE2001142455 DE10142455A1 (de) 2001-08-31 2001-08-31 Kombinationspräparate von arylsubstituierten Propanolderivaten mit weiteren Wirkstoffen und deren Verwendung

Publications (1)

Publication Number Publication Date
PE20030358A1 true PE20030358A1 (es) 2003-04-23

Family

ID=26009945

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000744A PE20030358A1 (es) 2001-08-22 2002-08-16 Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas

Country Status (21)

Country Link
US (1) US20030158094A1 (es)
EP (1) EP1420826A2 (es)
JP (1) JP2005505538A (es)
KR (1) KR20040027963A (es)
CN (1) CN1638801A (es)
AR (1) AR035284A1 (es)
BR (1) BR0211995A (es)
CA (1) CA2457974A1 (es)
CO (1) CO5560569A2 (es)
HR (1) HRP20040172A2 (es)
HU (1) HUP0401908A2 (es)
IL (1) IL160475A0 (es)
MX (1) MXPA04001256A (es)
NO (1) NO20040726L (es)
NZ (1) NZ531292A (es)
PA (1) PA8553101A1 (es)
PE (1) PE20030358A1 (es)
PL (1) PL366855A1 (es)
RU (1) RU2004108120A (es)
UY (1) UY27418A1 (es)
WO (1) WO2003018059A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
PL1791542T3 (pl) 2004-08-23 2015-11-30 Mannkind Corp Sole diketopiperazyny do dostarczania leków
AU2006290870B2 (en) 2005-09-14 2013-02-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
EP2497484A3 (en) 2006-02-22 2012-11-07 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2570147T3 (da) 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023245A (en) * 1987-11-10 1991-06-11 Hauser-Kuhrts, Inc. Improved niacin formulation
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater
DE19845402B4 (de) * 1998-10-02 2005-04-07 Aventis Pharma Deutschland Gmbh Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845406C2 (de) * 1998-10-02 2001-10-18 Aventis Pharma Gmbh Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
IL143944A0 (en) * 1998-12-23 2002-04-21 Searle Llc Combinations for cardiovascular indications

Also Published As

Publication number Publication date
WO2003018059A2 (de) 2003-03-06
US20030158094A1 (en) 2003-08-21
IL160475A0 (en) 2004-07-25
NZ531292A (en) 2005-08-26
PL366855A1 (en) 2005-02-07
AR035284A1 (es) 2004-05-05
NO20040726L (no) 2004-02-19
UY27418A1 (es) 2002-11-29
KR20040027963A (ko) 2004-04-01
MXPA04001256A (es) 2004-05-27
CO5560569A2 (es) 2005-09-30
WO2003018059A3 (de) 2003-11-13
CA2457974A1 (en) 2003-03-06
JP2005505538A (ja) 2005-02-24
PA8553101A1 (es) 2003-06-30
EP1420826A2 (de) 2004-05-26
HRP20040172A2 (en) 2004-10-31
CN1638801A (zh) 2005-07-13
BR0211995A (pt) 2004-09-28
HUP0401908A2 (hu) 2005-01-28
RU2004108120A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
PE20030358A1 (es) Formulacion en combinacion de derivados de propanol amina sustituidos con arilo, junto con otras sustancias activas
UY27357A1 (es) Nuevos agentes antidiabéticos .
PE20061124A1 (es) Compuestos y derivados de dibencil amina
AR037247A1 (es) Compuestos inhibidores de dipeptidil peptidasa iv (dp-iv), sus composiciones farmaceuticas y usos, y metodos de tratamiento de enfermedades de humanos tales como tolerancia alterada a la glucosa, diabetes tipo 2 e hiperglucemia
PE20011348A1 (es) Agentes antivirales de imidazopiridina e imidazopimiridina
AR034010A1 (es) Difenilazetidinonas, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos
GT200300268A (es) Nuevos derivados fluoroglucosidos heterociclicos, medicamentos que contienen estos compuestos y el uso de los mismos
GT200100146A (es) Activadores de glucoquinasa acetamida benzenica sustituida con atomos de alfa-acilo y alfa-heteroatomo.
DE60034354D1 (de) Verbindungen zum schutz von hydroxylgruppen und ihre anwendung
AR063786A1 (es) Derivados de 1,4 -benzotiepina-1,1 dioxido sustituidos con radicales bencilo, productos farmaceuticos que comprenden estos compuestos y su uso
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
AR035631A1 (es) Compuestos quimicos
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
PT1200426E (pt) Tieno-3-il-sulfonilamino (tio) carbonil-triazolino (ti) onas substituidas
CO5271675A1 (es) Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen
PE20040666A1 (es) Derivados novedosos de piperidina
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
ATE234847T1 (de) Organosiliziumverbindungen mit n-substituierter benzimidazol-benzazolgruppe oder benzofuranyl- benzazolgruppe, diese enthaltende sonnenschutzzusammensetzungen, und deren verwendungen
AR037940A1 (es) Compuestos antivirales de piridoquinoxalina
AR029005A1 (es) FORMULACION LíQUIDA ESTABLE SIN AGUA O CASI SIN AGUA DE BENCIMIDAZOLES SUSTITUIDOS, PROCESO PARA SU PREPARACIoN, USO DE ESTA FORMULACIoN, Y USO DE POLIETILENGLICOL Y UNA SAL DE SODIO O POTASIO DE UN INHIBIDOR DE H+, K+-ATP ASA
FI961507A (fi) Antrasyklinonijohdannaiset ja niiden käyttö amyloidoosissa
NO20022379D0 (no) Nye tiazolidinedionderivater som antidiabetiske midler
TW200505446A (en) Inhibitor of cox
AR064480A1 (es) Derivados de espiro-piperidina
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal